Industry: Medical Devices & Consumables
Published Date: 2026-01-05
Pages: 99 Pages
Report ld: 5572382
Request Sample
Customized Report
Transcutaneous Bilirubin Meters Market Size(US$)

CAGR 2026-2032
1.3%
Market Size,2032
USD 113
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Transcutaneous Bilirubin Meters market size was US$ 105 million in 2025 and is forecast to reach a readjusted size of US$ 113 million by 2032 with a CAGR of 1.3% during the forecast period 2026-2032.
The core drivers of the development of the transcutaneous bilirubin meter industry are twofold. First, the high incidence of neonatal jaundice creates a rigid clinical demand. The prevalence of jaundice in full-term and premature infants makes non-invasive and rapid testing equipment a necessity for neonatal health protection. Second, policy-driven improvements in the neonatal disease screening capabilities of primary healthcare systems, with relevant regulations listing transcutaneous bilirubin testing as a recommended method, coupled with the popularization and upgrading of equipment in primary healthcare institutions, continue to release market demand.
In 2024, global Transcutaneous Bilirubin Meters reached approximately 55,813 Units, with an average global market price of around 1,918.0 USD per Unit.
Transcutaneous Bilirubin Meters are non-invasive medical devices used to measure the level of bilirubin in a patient’s skin, primarily in neonates, to assess the risk of jaundice. These meters work by using light to estimate the bilirubin concentration in the subcutaneous tissue, which can be an indicator of the liver's ability to process bilirubin.
Transcutaneous bilirubin measurement is performed by placing a sensor on the baby’s skin, usually on the forehead or chest, where the skin is thin. The device emits light at specific wavelengths, and based on the amount of light that is absorbed or reflected by the skin, the device calculates the bilirubin level. This method provides a quick, painless alternative to serum bilirubin tests, reducing the need for blood draws.
The upstream core components of Transcutaneous Bilirubin Meters mainly include light sources, photoelectric sensors, filters, microprocessors, etc. Typical suppliers include Hamamatsu Photonics, Nichia, Edmund Optics, Thorlabs, etc. The downstream applications are mainly in hospitals, clinics, community service centers, and postpartum care centers.
The single-line production capacity of Transcutaneous Bilirubin Meters varies significantly depending on the manufacturer's scale, product positioning, and production model. Typically, the single-line production capacity of regular products is over 2,000 units, and the industry gross profit margin is in the range of 40%-60%.
Transcutaneous Bilirubin Meters are non-invasive sentinels protecting newborn health. Designed specifically for neonatal jaundice screening, these medical devices utilize spectral absorption technology. Simply place the probe lightly against the infant's forehead or sternum, and within seconds, the difference in reflection between blue and green light is used to calculate bilirubin levels, completely eliminating the pain and waiting associated with traditional blood tests. From bedside screening in maternity wards to routine monitoring in primary care hospitals and home follow-up, this device, with its non-invasive, rapid, and safe characteristics, has become a key tool for the early detection and intervention of neonatal hyperbilirubinemia, building the first line of defense for the health of millions of newborns worldwide.
The global market for Transcutaneous Bilirubin Meters exhibits a distinct regional development pattern. North America, relying on its mature neonatal healthcare system and high medical investment, has stable and concentrated market demand. Local companies have accumulated deep expertise in device intelligence and clinical adaptability, occupying a core position in the global market. Europe excels in technological precision, with stringent medical standards driving equipment upgrades towards low-interference, high-precision solutions. Products not only serve the well-developed local healthcare network but also radiate globally through technology exports. The Asia-Pacific region has become the core engine of industry growth. China, with its large newborn population and policies promoting the widespread availability of basic medical equipment, has propelled domestic brands from followers to leaders. Meanwhile, emerging markets such as India and Southeast Asia, with their improving healthcare infrastructure, are releasing strong incremental demand. According to our data, in 2024, Asia held nearly 50% of the market share for Transcutaneous Bilirubin Meters, followed by Europe and North America. During the forecast period, emerging markets such as India and Southeast Asia are leading the global growth rate.
From a manufacturer perspective, globally, key manufacturers of Transcutaneous Bilirubin Meters include Dräger, Mennen Medical, Philips, Konica Minolta, Beijing Maibang Optoelectronics, Ningbo Davy Medical, Weicai, AVI Healthcare, NEORUBIN (RECOVE GROUP), Nanjing Daofen Electronics, Likang Biotechnology, Boke Biotechnology, and Micro Lab. According to our data, the top 5 manufacturers accounted for over 70% of the global market share in 2024.
The convergence of multiple demands and policies has injected continuous growth momentum into the Transcutaneous Bilirubin Meters industry. The high incidence of neonatal jaundice forms a rigid demand foundation, while the monitoring needs of premature and high-risk infants further make the equipment a clinical necessity. At the policy level, countries are incorporating neonatal disease screening into their public health systems, while technological innovation is reshaping product value. Multi-wavelength spectral technology overcomes the bottleneck of skin color interference, and intelligent algorithms enable real-time data transmission and trend prediction, upgrading the equipment from a simple testing tool to an entry point for neonatal health management. Meanwhile, the public's growing preference for non-invasive medical care and increased awareness of home health monitoring have further broadened application scenarios, extending from hospitals to homes and forming a full-cycle monitoring ecosystem.
The global Transcutaneous Bilirubin Meters market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Transcutaneous Bilirubin Meters sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Transcutaneous Bilirubin Meters manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Transcutaneous Bilirubin Meters product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Transcutaneous Bilirubin Meters value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Transcutaneous Bilirubin Meters Product Scope
1.2 Transcutaneous Bilirubin Meters by Type
1.2.1 Global Transcutaneous Bilirubin Meters Sales by Type (2021, 2025 & 2032)
1.2.2 Standard Type
1.2.3 Intelligent Type
1.3 Transcutaneous Bilirubin Meters by Application
1.3.1 Global Transcutaneous Bilirubin Meters Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Transcutaneous Bilirubin Meters Market Estimates and Forecasts (2021-2032)
1.4.1 Global Transcutaneous Bilirubin Meters Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Transcutaneous Bilirubin Meters Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Transcutaneous Bilirubin Meters Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Transcutaneous Bilirubin Meters Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Transcutaneous Bilirubin Meters Historical Market Scenario by Region (2021-2026)
2.2.1 Global Transcutaneous Bilirubin Meters Sales Market Share by Region (2021-2026)
2.2.2 Global Transcutaneous Bilirubin Meters Revenue Market Share by Region (2021-2026)
2.3 Global Transcutaneous Bilirubin Meters Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Transcutaneous Bilirubin Meters Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Transcutaneous Bilirubin Meters Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Transcutaneous Bilirubin Meters Market Size and Prospects (2021-2032)
2.4.2 Europe Transcutaneous Bilirubin Meters Market Size and Prospects (2021-2032)
2.4.3 China Transcutaneous Bilirubin Meters Market Size and Prospects (2021-2032)
2.4.4 Japan Transcutaneous Bilirubin Meters Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Transcutaneous Bilirubin Meters Historical Market Review by Type (2021-2026)
3.1.1 Global Transcutaneous Bilirubin Meters Sales by Type (2021-2026)
3.1.2 Global Transcutaneous Bilirubin Meters Revenue by Type (2021-2026)
3.1.3 Global Transcutaneous Bilirubin Meters Average Price by Type (2021-2026)
3.2 Global Transcutaneous Bilirubin Meters Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Transcutaneous Bilirubin Meters Sales Forecast by Type (2027-2032)
3.2.2 Global Transcutaneous Bilirubin Meters Revenue Forecast by Type (2027-2032)
3.2.3 Global Transcutaneous Bilirubin Meters Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Transcutaneous Bilirubin Meters
4 Global Market Size by Application
4.1 Global Transcutaneous Bilirubin Meters Historical Market Review by Application (2021-2026)
4.1.1 Global Transcutaneous Bilirubin Meters Sales by Application (2021-2026)
4.1.2 Global Transcutaneous Bilirubin Meters Revenue by Application (2021-2026)
4.1.3 Global Transcutaneous Bilirubin Meters Average Price by Application (2021-2026)
4.2 Global Transcutaneous Bilirubin Meters Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Transcutaneous Bilirubin Meters Sales Forecast by Application (2027-2032)
4.2.2 Global Transcutaneous Bilirubin Meters Revenue Forecast by Application (2027-2032)
4.2.3 Global Transcutaneous Bilirubin Meters Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Transcutaneous Bilirubin Meters Applications
5 Competition Landscape by Players
5.1 Global Transcutaneous Bilirubin Meters Sales by Player (2021-2026)
5.2 Global Top Transcutaneous Bilirubin Meters Players by Revenue (2021-2026)
5.3 Global Transcutaneous Bilirubin Meters Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Transcutaneous Bilirubin Meters revenue as of 2025
5.4 Global Transcutaneous Bilirubin Meters Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Transcutaneous Bilirubin Meters, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Transcutaneous Bilirubin Meters, Product Type & Application
5.7 Global Key Manufacturers of Transcutaneous Bilirubin Meters, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Transcutaneous Bilirubin Meters Sales by Company
6.1.1.1 North America Transcutaneous Bilirubin Meters Sales by Company (2021-2026)
6.1.1.2 North America Transcutaneous Bilirubin Meters Revenue by Company (2021-2026)
6.1.2 North America Transcutaneous Bilirubin Meters Sales Breakdown by Type (2021-2026)
6.1.3 North America Transcutaneous Bilirubin Meters Sales Breakdown by Application (2021-2026)
6.1.4 North America Transcutaneous Bilirubin Meters Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Transcutaneous Bilirubin Meters Sales by Company
6.2.1.1 Europe Transcutaneous Bilirubin Meters Sales by Company (2021-2026)
6.2.1.2 Europe Transcutaneous Bilirubin Meters Revenue by Company (2021-2026)
6.2.2 Europe Transcutaneous Bilirubin Meters Sales Breakdown by Type (2021-2026)
6.2.3 Europe Transcutaneous Bilirubin Meters Sales Breakdown by Application (2021-2026)
6.2.4 Europe Transcutaneous Bilirubin Meters Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Transcutaneous Bilirubin Meters Sales by Company
6.3.1.1 China Transcutaneous Bilirubin Meters Sales by Company (2021-2026)
6.3.1.2 China Transcutaneous Bilirubin Meters Revenue by Company (2021-2026)
6.3.2 China Transcutaneous Bilirubin Meters Sales Breakdown by Type (2021-2026)
6.3.3 China Transcutaneous Bilirubin Meters Sales Breakdown by Application (2021-2026)
6.3.4 China Transcutaneous Bilirubin Meters Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Transcutaneous Bilirubin Meters Sales by Company
6.4.1.1 Japan Transcutaneous Bilirubin Meters Sales by Company (2021-2026)
6.4.1.2 Japan Transcutaneous Bilirubin Meters Revenue by Company (2021-2026)
6.4.2 Japan Transcutaneous Bilirubin Meters Sales Breakdown by Type (2021-2026)
6.4.3 Japan Transcutaneous Bilirubin Meters Sales Breakdown by Application (2021-2026)
6.4.4 Japan Transcutaneous Bilirubin Meters Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Dräger
7.1.1 Dräger Company Information
7.1.2 Dräger Business Overview
7.1.3 Dräger Transcutaneous Bilirubin Meters Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Dräger Transcutaneous Bilirubin Meters Products Offered
7.1.5 Dräger Recent Development
7.2 Mennen Medical
7.2.1 Mennen Medical Company Information
7.2.2 Mennen Medical Business Overview
7.2.3 Mennen Medical Transcutaneous Bilirubin Meters Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Mennen Medical Transcutaneous Bilirubin Meters Products Offered
7.2.5 Mennen Medical Recent Development
7.3 Philips
7.3.1 Philips Company Information
7.3.2 Philips Business Overview
7.3.3 Philips Transcutaneous Bilirubin Meters Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Philips Transcutaneous Bilirubin Meters Products Offered
7.3.5 Philips Recent Development
7.4 Konica Minolta
7.4.1 Konica Minolta Company Information
7.4.2 Konica Minolta Business Overview
7.4.3 Konica Minolta Transcutaneous Bilirubin Meters Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Konica Minolta Transcutaneous Bilirubin Meters Products Offered
7.4.5 Konica Minolta Recent Development
7.5 Beijing M&B Electronic Instruments
7.5.1 Beijing M&B Electronic Instruments Company Information
7.5.2 Beijing M&B Electronic Instruments Business Overview
7.5.3 Beijing M&B Electronic Instruments Transcutaneous Bilirubin Meters Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Beijing M&B Electronic Instruments Transcutaneous Bilirubin Meters Products Offered
7.5.5 Beijing M&B Electronic Instruments Recent Development
7.6 Ningbo David Medical Device
7.6.1 Ningbo David Medical Device Company Information
7.6.2 Ningbo David Medical Device Business Overview
7.6.3 Ningbo David Medical Device Transcutaneous Bilirubin Meters Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Ningbo David Medical Device Transcutaneous Bilirubin Meters Products Offered
7.6.5 Ningbo David Medical Device Recent Development
7.7 VECH MEDICAL
7.7.1 VECH MEDICAL Company Information
7.7.2 VECH MEDICAL Business Overview
7.7.3 VECH MEDICAL Transcutaneous Bilirubin Meters Sales, Revenue and Gross Margin (2021-2026)
7.7.4 VECH MEDICAL Transcutaneous Bilirubin Meters Products Offered
7.7.5 VECH MEDICAL Recent Development
7.8 AVI Healthcare
7.8.1 AVI Healthcare Company Information
7.8.2 AVI Healthcare Business Overview
7.8.3 AVI Healthcare Transcutaneous Bilirubin Meters Sales, Revenue and Gross Margin (2021-2026)
7.8.4 AVI Healthcare Transcutaneous Bilirubin Meters Products Offered
7.8.5 AVI Healthcare Recent Development
7.9 NEORUBIN (RECOVE GROUP)
7.9.1 NEORUBIN (RECOVE GROUP) Company Information
7.9.2 NEORUBIN (RECOVE GROUP) Business Overview
7.9.3 NEORUBIN (RECOVE GROUP) Transcutaneous Bilirubin Meters Sales, Revenue and Gross Margin (2021-2026)
7.9.4 NEORUBIN (RECOVE GROUP) Transcutaneous Bilirubin Meters Products Offered
7.9.5 NEORUBIN (RECOVE GROUP) Recent Development
7.10 Dolphin Nanjing electronics
7.10.1 Dolphin Nanjing electronics Company Information
7.10.2 Dolphin Nanjing electronics Business Overview
7.10.3 Dolphin Nanjing electronics Transcutaneous Bilirubin Meters Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Dolphin Nanjing electronics Transcutaneous Bilirubin Meters Products Offered
7.10.5 Dolphin Nanjing electronics Recent Development
7.11 Heal Force
7.11.1 Heal Force Company Information
7.11.2 Heal Force Business Overview
7.11.3 Heal Force Transcutaneous Bilirubin Meters Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Heal Force Transcutaneous Bilirubin Meters Products Offered
7.11.5 Heal Force Recent Development
7.12 BIOBASE GROUP
7.12.1 BIOBASE GROUP Company Information
7.12.2 BIOBASE GROUP Business Overview
7.12.3 BIOBASE GROUP Transcutaneous Bilirubin Meters Sales, Revenue and Gross Margin (2021-2026)
7.12.4 BIOBASE GROUP Transcutaneous Bilirubin Meters Products Offered
7.12.5 BIOBASE GROUP Recent Development
7.13 Micro Lab
7.13.1 Micro Lab Company Information
7.13.2 Micro Lab Business Overview
7.13.3 Micro Lab Transcutaneous Bilirubin Meters Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Micro Lab Transcutaneous Bilirubin Meters Products Offered
7.13.5 Micro Lab Recent Development
8 Transcutaneous Bilirubin Meters Manufacturing Cost Analysis
8.1 Transcutaneous Bilirubin Meters Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Transcutaneous Bilirubin Meters
8.4 Transcutaneous Bilirubin Meters Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Transcutaneous Bilirubin Meters Distributors List
9.3 Transcutaneous Bilirubin Meters Customers
10 Transcutaneous Bilirubin Meters Market Dynamics
10.1 Transcutaneous Bilirubin Meters Industry Trends
10.2 Transcutaneous Bilirubin Meters Market Drivers
10.3 Transcutaneous Bilirubin Meters Market Challenges
10.4 Transcutaneous Bilirubin Meters Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Transcutaneous Bilirubin Meters market was valued at US$ 105 million in 2025 and is anticipated to reach US$ 113 million by 2032, at a CAGR of 1.3% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 126
USD 2900.00
(Single User License)
The global market for Transcutaneous Bilirubin Meters was estimated to be worth US$ 105 million in 2025 and is projected to reach US$ 113 million, growing at a CAGR of 1.3% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 115
USD 3950.00
(Single User License)
The global market for Transcutaneous Bilirubin Meters was estimated to be worth US$ 107.05 million in 2024 and is forecast to a readjusted size of US$ 103.09 million by 2031 with a CAGR of -0.30% during the forecast period 2025-2031.
Published Date: 2025-12-01
Pages: 178
USD 3950.00
(Single User License)
The global Transcutaneous Bilirubin Meters market size was US$ 101 million in 2024 and is forecast to a readjusted size of US$ 122 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 102
USD 4250.00
(Single User License)
The global Transcutaneous Bilirubin Meters market is projected to grow from US$ 101 million in 2024 to US$ 122 million by 2031, at a CAGR of 2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 175
USD 4900.00
(Single User License)
The global market for Transcutaneous Bilirubin Meters was estimated to be worth US$ 101 million in 2024 and is forecast to a readjusted size of US$ 122 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 144
USD 3950.00
(Single User License)
The global market for Transcutaneous Bilirubin Meters was valued at US$ 101 million in the year 2024 and is projected to reach a revised size of US$ 122 million by 2031, growing at a CAGR of 2.8% during the forecast period.
Published Date: 2025-01-13
Pages: 103
USD 2900.00
(Single User License)
A transcutaneous bilirubin meters is a device that measures the yellowish pigmentation of the skin and other mucous membranes caused by hyperbilirubinemia (increased levels of bilirubin in the blood). They are widely used in children's hospitals, baby care centers all over the world.
Published Date: 2024-04-28
Pages: 112
USD 4900.00
(Single User License)
A transcutaneous bilirubin meters is a device that measures the yellowish pigmentation of the skin and other mucous membranes caused by hyperbilirubinemia (increased levels of bilirubin in the blood). They are widely used in children's hospitals, baby care centers all over the world.
Published Date: 2024-02-05
Pages: 97
USD 2900.00
(Single User License)
The global Transcutaneous Bilirubin Meters market was valued at US$ 105 million in 2025 and is anticipated to reach US$ 113 million by 2032, at a CAGR of 1.3% from 2026 to 2032.
Published: 2026-01-05
Pages: 126
The global market for Transcutaneous Bilirubin Meters was estimated to be worth US$ 105 million in 2025 and is projected to reach US$ 113 million, growing at a CAGR of 1.3% from 2026 to 2032.
Published: 2026-01-05
Pages: 115
The global market for Transcutaneous Bilirubin Meters was estimated to be worth US$ 107.05 million in 2024 and is forecast to a readjusted size of US$ 103.09 million by 2031 with a CAGR of -0.30% during the forecast period 2025-2031.
Published: 2025-12-01
Pages: 178
The global Transcutaneous Bilirubin Meters market size was US$ 101 million in 2024 and is forecast to a readjusted size of US$ 122 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 102
The global Transcutaneous Bilirubin Meters market is projected to grow from US$ 101 million in 2024 to US$ 122 million by 2031, at a CAGR of 2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 175
The global market for Transcutaneous Bilirubin Meters was estimated to be worth US$ 101 million in 2024 and is forecast to a readjusted size of US$ 122 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 144
The global market for Transcutaneous Bilirubin Meters was valued at US$ 101 million in the year 2024 and is projected to reach a revised size of US$ 122 million by 2031, growing at a CAGR of 2.8% during the forecast period.
Published: 2025-01-13
Pages: 103
A transcutaneous bilirubin meters is a device that measures the yellowish pigmentation of the skin and other mucous membranes caused by hyperbilirubinemia (increased levels of bilirubin in the blood). They are widely used in children's hospitals, baby care centers all over the world.
Published: 2024-04-28
Pages: 112
A transcutaneous bilirubin meters is a device that measures the yellowish pigmentation of the skin and other mucous membranes caused by hyperbilirubinemia (increased levels of bilirubin in the blood). They are widely used in children's hospitals, baby care centers all over the world.
Published: 2024-02-05
Pages: 97
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now